Market Overview:
The global specimen validity testing market size is expected to reach USD 2.52 billion by 2032,exhibiting the CAGR of 6.2% during the forecast period.
What is Specimen Validity Testing?
Some donors might attempt to mask their urine specimen by putting on materials such as domestic chemicals, oxidants, detoxifiers, and so on in the course of drug testing, as affirmative test outcomes have vocational and legitimate effects. Specimen validity testing is engaged to verify the probity of a urine drug test outcome. It trails profoundly into the urine test outcomes and guarantees that the urine specimen was that of a human bereft of tampering.
Download Free Sample PDF Copy of the Report:
Company Profiles
These prominent market players are applying progressive technologies to deal with the excessively discounted requirements of consumers. These players concentrate on deliberated alliances, contemporary product instigation, and commercialization for market augmentation. Some of the market leaders are as follows:
- Abbott (US)
- Alfa Scientific Designs (US)
- Healgen Scientific LLC (US)
- LabCorp (US)
- Nona Scientific Laboratory (US)
- Omega Laboratories (Canada)
- Premier Biotech, Inc. (US)
- Quest Diagnostics (US)
- Rochester Regional Health (US)
- Sciteck, Inc. (US)
- Siemens Healthineers (Germany)
- Thermo Fisher Scientific (US)
- Vision Diagnostics, Inc. (India)
Growth Prospects and Trends
The specimen validity testing market is expanding due to the continuing inventiveness of government bodies to lessen the usage of drugs by persons, improve security in the public domain, and ease market demand worldwide. The consumption of drugs by railway drivers, government buses, and the aeronautics industry can cause massive human losses, generating an immediate requirement for specimen validity testing.
Moreover, the growing cases of lawbreakers are disclosing the prerequisite of testing the security and integrity of samples as it permits the controller agents to comprehend the dependability of specimens and, consequently, the results. The growing worries about safeguarding people from wrong medical drug testing outcomes and the worthier interests in walloping lawbreakers and rescuing unimpeachable people are anticipated to generate notable growth possibilities in the upcoming years.
Regional Insights
- North America makes up the majority of the market due to its robust healthcare framework and superlative market players. The increasing aggregate of urine tests is easing the notable demand for specimen validity testing in the regional trade center.
- Throughout the projection period, the Asia Pacific market is expected to grow at a faster CAGR. This results from the growing intake of illegitimate drugs in some nations. The prevalence of unlawful drug conveyance is motivating government powers to carry out deference and precise drug screening ventures, which will ignite the acquisition of these sample probity testing instruments in the region in the near future.
Specimen Validity Testing Market, Regional Outlook (Revenue, USD Billion, 2019-2032)
- North America
- Type Outlook
- Laboratory Testing
- Rapid/POC Testing
- Product & Services Outlook
- Products
- Assay Kits
- Reagents and Calibrators
- Disposables
- Services
- Products
- Drug Type Outlook
- Antibacterial Drugs
- Antifungal Drugs
- Antiviral Drugs
- Others
- Indication Outlook
- Bloodstream Infections
- Urinary Tract Infections
- Surgical Site Infections
- Pneumonia
- Others
- End-User Outlook
- Drug Screening Laboratories
- Pain Management Centers
- Drug Rehabilitation Centre
- Workplace
- Others
- Type Outlook
Recent Developments in the Diagnostic Industry:
- Validity Diagnostics Receives Patent for Urine Drug Screen Validity Testing Panels (February 2022):
Validity Diagnostics, a leading producer of diagnostic products, announced that it had been granted a patent by the United States Patent and Trademark Office. The patent relates to the company’s innovative urine drug screen validity testing panels, a significant advancement aimed at improving the accuracy and reliability of drug testing processes.
The rising need for abuse testing at the global level highly drives the growth of the specimen validity testing market. The potential to identify the individual’s drug intake and other food intake with specimen validity testing is facilitating its adoption in legal and forensic science activities. The significant rise in sample tampering and growing concerns about the security and safety of urine samples encouraged legal officers to check the integrity of the sample with specimen validity testing tools.